Srikant Rangaraju

Comparison of Final Infarct Volumes in Patients Who Received Endovascular Therapy or Intravenous Thrombolysis for Acute Intracranial Large-Vessel Occlusions.

Status epilepticus following inhalational exposure to bifenthrin, a Type II pyrethroid.

Pittsburgh Response to Endovascular therapy (PRE) score: optimizing patient selection for endovascular therapy for large vessel occlusion strokes.

Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease.

Perfusion imaging in the 3-hour time window predicts a tPA-associated hemorrhage in acute ischemic stroke.

Sulcal effacement with preserved gray-white junction: a sign of reversible ischemia.

Relationship Between Lesion Topology and Clinical Outcome in Anterior Circulation Large Vessel Occlusions.

Endovascular Therapy in Strokes with ASPECTS 5-7 May Result in Smaller Infarcts and Better Outcomes as Compared to Medical Treatment Alone.

Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.

Streamlining door to recanalization processes in endovascular stroke therapy.

Prognostic Value of the 24-Hour Neurological Examination in Anterior Circulation Ischemic Stroke: A post hoc Analysis of Two Randomized Controlled Stroke Trials.

Automated CT Perfusion Ischemic Core Volume and Noncontrast CT ASPECTS (Alberta Stroke Program Early CT Score): Correlation and Clinical Outcome Prediction in Large Vessel Stroke.

Neurologic Examination at 24 to 48 Hours Predicts Functional Outcomes in Basilar Artery Occlusion Stroke.

Pittsburgh response to endovascular therapy score as a pre-treatment prognostic tool: External validation in Trevo2.

Regulatory B Cells Induce Formation of IL-10-Expressing T Cells in Mice with Autoimmune Neuroinflammation.

Comparison of 3-Month Stroke Disability and Quality of Life across Modified Rankin Scale Categories.

A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation.

Selection Paradigms for Large Vessel Occlusion Acute Ischemic Stroke Endovascular Therapy.

Abbreviation of the Follow-Up NIH Stroke Scale Using Factor Analysis.

Predictors of Good Outcome After Endovascular Therapy for Vertebrobasilar Occlusion Stroke.

Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.

Atrial Fibrillation Predictors on Mobile Cardiac Telemetry in Cryptogenic Ischemic Stroke.

Frequency of and Factors Associated With Obstructive Sleep Apnea and Periodic Limb Movements in Stroke and TIA Patients.

Differential Phagocytic Properties of CD45 Microglia and CD45 Brain Mononuclear Phagocytes-Activation and Age-Related Effects.

A Review of Pre-Intervention Prognostic Scores for Early Prognostication and Patient Selection in Endovascular Management of Large Vessel Occlusion Stroke.

Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.

Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.

Deep Hypothermia With Retrograde Cerebral Perfusion Versus Moderate Hypothermia With Antegrade Cerebral Perfusion for Arch Surgery.

Prognostic importance of CT ASPECTS and CT perfusion measures of infarction in anterior emergent large vessel occlusions.

Coagulation markers and echocardiography predict atrial fibrillation, malignancy or recurrent stroke after cryptogenic stroke.

Temporal profiling of Kv1.3 channel expression in brain mononuclear phagocytes following ischemic stroke.

Transcriptional regulation of homeostatic and disease-associated-microglial genes by IRF1, LXRβ, and CEBPα.

Recurrent Hemispheric Stroke Syndromes in Symptomatic Atherosclerotic Internal Carotid Artery Occlusions: The Carotid Occlusion Surgery Study Randomized Trial.

Estimating the social value of mechanical thrombectomy randomized trials on an established stroke network.

Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells.

Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.

Markers of coagulation and hemostatic activation aid in identifying causes of cryptogenic stroke.

Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage.

Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer's disease.

Predicting Outcomes After Acute Reperfusion Therapy for Basilar Artery Occlusion.